- Nurofen and Dettel manufacturer Reckitt warns of potential £150m hit from Iran war oil costs Yorkshire Post —
- Dettol maker Reckitt warns of lower margins after quarterly sales miss Irish Times —
- Reckitt shares slump as Durex owner takes £150m Iran war hit City AM —
- Reckitt cautions over impact of Iran war on costs and consumer demand The Standard —
- Reckitt cautions over impact of Iran war on costs and consumer demand The Independent —
- Reckitt cautions over impact of Iran war on costs and consumer demand The Independent —
- Reckitt cautions over impact of Iran war on costs and consumer demand Belfast Telegraph —
- Reckitt Sales Hit by Lackluster US Demand for Cold Medicines Bloomberg —
- Reckitt’s Like-for-Like Revenue Rises on Emerging Markets Performance Wall Street Journal —
- Reckitt cautions over impact of Iran war on costs and consumer demand LBC —
Nurofen
Drug brand name
Nurofen is a brand of range of pain-relief medication containing ibuprofen made by the English-Dutch company Reckitt Benckiser. Introduced in 1983, the Nurofen brand was acquired following Reckitt Benckiser's acquisition of Boots healthcare international in 2005 for £1.93 billion, which included Nurofen, Strepsils, and Clearasil. The brand is primarily marketed and sold in the United Kingdom, other parts of Europe, South Africa, Australia and New Zealand. In 2016, it was the biggest selling branded over-the-counter medication sold in Great Britain, with sales of £116.8 million.